Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana M Eccles

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Breast Cancer Research : BCR|January 9, 2009
Identification of personal risk of breast cancer: geneticsDiana M Eccles
Lancet (London, England)|January 18, 2003
Genetic testing for BRCA1 mutation in the UKDiana M Eccles,
Familial Cancer|June 1, 2006
Familial cancer (special issue) breast cancer treatment and geneticsDiana M Eccles
The Lancet. Oncology|September 1, 2005
Familial non-BRCA1/BRCA2-associated breast cancerDiana M Eccles, Gabriella Pichert
The Lancet. Oncology|April 4, 2018
Genetic testing for young women with breast cancer - Authors' replyDiana M Eccles, Ellen R Copson
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Prohibitin 3' untranslated region polymorphism and breast cancer riskIan G Campbell, James Allen, Diana M Eccles
JAMA Oncology|August 22, 2018
Hereditary Breast and Ovarian Cancer Testing in the Genomic EraStephanie L Greville-Heygate, Diana M Eccles, Lucy E Side
Cancer Letters|October 22, 2005
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancerIan G Campbell, Diana M Eccles, David Y H Choong
Breast Cancer Research : BCR|June 26, 2004
The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control studyKaren G Montgomery, Mira C P Liu, Diana M Eccles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2002
Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancerSimon W Baxter, David Y H Choong, Diana M Eccles, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Breast Cancer Research : BCR|January 9, 2009
Identification of personal risk of breast cancer: geneticsDiana M Eccles
Lancet (London, England)|January 18, 2003
Genetic testing for BRCA1 mutation in the UKDiana M Eccles,
Familial Cancer|June 1, 2006
Familial cancer (special issue) breast cancer treatment and geneticsDiana M Eccles
The Lancet. Oncology|September 1, 2005
Familial non-BRCA1/BRCA2-associated breast cancerDiana M Eccles, Gabriella Pichert
The Lancet. Oncology|April 4, 2018
Genetic testing for young women with breast cancer - Authors' replyDiana M Eccles, Ellen R Copson
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Prohibitin 3' untranslated region polymorphism and breast cancer riskIan G Campbell, James Allen, Diana M Eccles
JAMA Oncology|August 22, 2018
Hereditary Breast and Ovarian Cancer Testing in the Genomic EraStephanie L Greville-Heygate, Diana M Eccles, Lucy E Side
Cancer Letters|October 22, 2005
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancerIan G Campbell, Diana M Eccles, David Y H Choong
Breast Cancer Research : BCR|June 26, 2004
The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control studyKaren G Montgomery, Mira C P Liu, Diana M Eccles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2002
Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancerSimon W Baxter, David Y H Choong, Diana M Eccles, et al.
Pageof 15